Trial intelligence / Profile preview

Celecoxib and Chemoradiation for Locally Advanced Cervical Cancer

NCT00023660Phase 2Completed

Sponsor
NRG Oncology
Start
Aug 2001
Primary completion
Jan 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of celecoxib in Cervical Cancer (CC), sponsored by NRG Oncology. Started Aug 2001; status: completed.

02

Drugs

celecoxib
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT00023660.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00023660.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call